Mumbai, Maharashtra, India — In a powerful and uplifting interview with Pharma Now, Mukesh Patale, Head of USP MSAT, Biologics at Dr. Reddy’s Laboratories, shares his deeply personal and professional journey, one that begins in a small town in Maharashtra and unfolds into a leadership role in the global biopharma industry. 

From being an average high school student with no clear focus to becoming a university topper in biotechnology, Mukesh’s transformation was driven by self-belief, discipline, and an unwavering passion for science. Without the advantages of campus placements or abundant resources, he carved out his first break at the prestigious National Chemical Laboratory (NCL), launching his career in upstream bioprocess development.

In the interview, Mukesh describes his fascination with upstream bioprocessing working with living cells to produce complex biological products as something akin to nurturing a baby or plant. This stage, he emphasizes, is the heart of biosimilar production, as most of the product’s quality and yield are determined during this phase. Particularly when dealing with mammalian cells used to create monoclonal antibodies and fusion proteins, he explains how precision in culture media and environmental conditions is crucial to maintaining therapeutic quality. Unlike traditional small-molecule pharmaceuticals where errors can often be corrected downstream, biologics require meticulous care right from the start.

Reflecting on the broader biopharma landscape, Mukesh discusses how the industry has evolved over the past two decades from a focus on generics to an increasing emphasis on biosimilars and next-generation treatments such as gene therapy, cell therapy, bispecific antibodies, and precision medicine. He highlights how India is quickly becoming a global leader in biosimilar development and manufacturing, thanks to its cost-effective processes and scientific talent. 

The conversation also explores how digital transformation, artificial intelligence (AI), and machine learning are revolutionizing bioprocess research and development. These technologies have dramatically reduced time and cost by enabling faster data analysis, optimizing experimental design, and improving predictive accuracy.

Mukesh places significant value on continuous learning and upskilling, sharing how he taught himself statistics and learned six sigma methodologies to stay ahead in an ever-evolving field. For him, staying relevant in bioprocessing requires professionals to proactively adopt new tools, adapt to changing technologies, and remain observant throughout the process. Leadership, he believes, goes far beyond technical skills. 

At Dr. Reddy’s, he focuses on mentoring young scientists by encouraging curiosity, helping them go beyond assigned roles, and recognizing their individual strengths. His leadership style is centered around open communication, constructive feedback, and maintaining positive qualities that build trust, team cohesion, and resilience, especially during high-pressure situations like process failures or scale-up challenges.

Looking ahead, Mukesh speaks about the complexities of scaling biological molecules from lab to manufacturing scale, a challenge far greater than simply scaling a team because biological systems are inherently sensitive. He believes that solving these technical problems with precision and patience is key to ensuring that biologics reach patients safely and effectively. As the industry moves toward cutting-edge therapies, he acknowledges that accessibility and affordability remain important goals, especially in emerging markets like India.

The interview concludes with a personal message of motivation. Mukesh’s guiding principle, “nothing is impossible,” reflects his belief in the power of perseverance, self-discipline, and internal motivation. He encourages young bioprocess professionals to dream big, take ownership of their growth, and never depend on external validation. His story is a shining example of how self-belief, adaptability, and passion can turn humble beginnings into impactful leadership in one of the world’s most advanced and meaningful scientific fields.

Watch the full podcast to uncover his inspiring journey to becoming a trailblazer in the biologics division. Click here:
Learn AI or Lose Your Job: Urgent Advice from Dr. Reddy’s Biologics Head